An analysis of the liquid by DEA forensic chemists revealed the substance was etonitazenes.
Un sitio oficial del Gobierno de Estados Unidos
Así es como usted puede verificarlo
Los sitios web seguros .gov usan HTTPS
Un candado (
) o https:// significa que usted se conectó de
forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.
BATON ROUGE, LA — The East Baton Rouge Sheriff’s Office (EBRSO), in coordination with the Drug Enforcement Administration (DEA) and local and state law enforcement partners, is announcing a significant development in its investigation into a large-scale clandestine drug manufacturing laboratory discovered in Baton Rouge on November 12.
DEA forensic testing has confirmed that the laboratory was being used to manufacture etonitazene, an extremely potent synthetic opioid belonging to a class of drugs known as nitazenes. According to the agency, the discovery represents the first known large-scale domestic nitazene synthesis laboratory dismantled by the agency in the United States.
The laboratory was discovered during a three-month investigation led by EBRSO Narcotics agents into suspected drug trafficking activities involving Torrey Lewis Jr., 34, of Baton Rouge.
On November 12, EBRSO agents, working alongside DEA and other law enforcement partners, executed three search warrants and discovered a sophisticated clandestine laboratory at 4830 Cottage Hill Drive.
The laboratory contained approximately $250,000 in professional-grade equipment, including a 100-liter reactor system, specialized temperature-control equipment, an industrial evaporator and numerous chemicals used in the manufacturing of synthetic drugs.
An analysis of the liquid by DEA forensic chemists revealed the substance was etonitazenes.
At the time of the discovery, the main reactor vessel contained approximately 58 liters of liquid. DEA forensic chemists from the South Central Laboratory in Dallas responded to assist with the investigation and analysis of the laboratory.
On November 18, investigators received laboratory results confirming that the liquid was etonitazene, a powerful synthetic opioid that has emerged as a growing threat to public health and safety.
Emerging Threat of Nitazenes
While nitazenes have existed for decades, traffickers are increasingly pushing these synthetic opioids into the illicit drug supply across Louisiana and the nation. Depending on the specific compound, nitazenes can match, or vastly exceed, the potency of fentanyl, creating an extraordinary risk of fatal overdose.
Traffickers frequently press nitazenes into counterfeit prescription pills or mix them into fentanyl, heroin, cocaine and xylazine, often without the user's knowledge. Because of their extreme potency, DEA warns that standard emergency interventions may fall short and multiple doses of naloxone (Narcan) may be required to reverse an overdose.
Forensic data shows Louisiana has become a primary hotspot for this emerging threat: the Louisiana State Police Crime Laboratory reports a recent uptick in nitazene-positive seizures, and more than 80% of all etonitazene exhibits seized by DEA nationwide this year have originated in the state.
The laboratory contained professional grade equipment, including a 100-liter reactor system.
Sheriff Gautreaux: Investigation Demonstrates Importance of Law Enforcement Partnerships
“This investigation was already significant because of the scale and sophistication of the laboratory our agents uncovered. Now, with confirmation that this operation involved the manufacturing of nitazenes and represents a first-of-its-kind discovery for DEA in the United States, the magnitude of what our investigators accomplished is even more extraordinary,” said East Baton Rouge Sheriff Sid J. Gautreaux III.
“I could not be prouder of the men and women of the East Baton Rouge Sheriff’s Office whose dedication, persistence and investigative expertise led to this discovery. For three months, our agents worked tirelessly to identify and dismantle this operation. Their work, combined with the invaluable assistance and specialized resources of our federal, state and local law enforcement partners, has removed an extremely dangerous drug manufacturing operation from our community.”
“This case is a powerful example of why strong partnerships among law enforcement agencies are so important. Criminal organizations and drug traffickers do not recognize jurisdictional boundaries, and neither can our efforts to stop them. I want to personally thank the DEA, Louisiana State Police and every agency and individual who contributed to this investigation. Their collaboration was instrumental in bringing this operation to an end.”
“Every day, families across our communities are suffering the devastating consequences of illegal drugs. The emergence of substances like nitazenes makes our mission even more urgent. We will continue using every resource available to identify those responsible for manufacturing and distributing these deadly substances and hold them accountable.”
The laboratory was discovered after a three-month investigation led by East Baton Rouge Sheriff's Office narcotics agents.
DEA Recognizes Significance of Discovery
“The dismantling of the first known large-scale nitazene synthesis laboratory in the United States marks a victory in our fight against deadly synthetic opioids,” said DEA New Orleans Field Division Special Agent in Charge John P. Scott. “As synthetic opioids continue to evolve, shutting down an active manufacturing source of this scale removes a severe threat to our communities and stops these dangerous drugs before they ever reach our streets. Working alongside our partners at the East Baton Rouge Sheriff’s Office, who led this historic investigation, as well as Louisiana State Police and other local partners, DEA remains relentless in targeting the individuals and networks producing these deadly substances.”
Additional Charges Filed
As a result of the new laboratory findings, investigators have added an additional charge against:
Torrey Lewis Jr.
DOB: April 19, 1992
Additional Charge:
Previously Announced Charges:
Lewis remains in custody and is currently being held without bond.
Original Investigation and Seizures
The investigation originated after Louisiana State Police Troop NOLA identified Lewis as a suspected source of fentanyl being distributed in the New Orleans area.
Following extensive surveillance and investigative efforts, EBRSO agents identified three locations associated with Lewis’s suspected drug trafficking activities.
Search warrants were executed at:
In addition to the clandestine laboratory and its equipment, investigators seized approximately 22.5 grams of fentanyl, 3 grams of cocaine, two rifles, $8,531 in currency and additional drug manufacturing and distribution paraphernalia.
The laboratory equipment and chemicals were removed by E3 Environmental, a specialized environmental response contractor.
Multiagency Collaboration
The East Baton Rouge Sheriff’s Office recognizes the assistance and contributions of the following partners:
Federal Agencies
State and Regional Agencies
Local Law Enforcement Agencies
East Baton Rouge Sheriff’s Office Divisions
Environmental Response
The investigation remains ongoing, and additional charges may be forthcoming.